Better Therapeutics Inc [NASDAQ: BTTX] traded at a low on Thursday, posting a -82.84 loss after which it closed the day’ session at $0.04. The company report on March 14, 2024 at 9:38 AM that Better Therapeutics Announces it will Seek Strategic Alternatives and will
Better Therapeutics Inc [NASDAQ: BTTX] closed the trading session at $0.17. The company report on February 20, 2024 at 9:25 AM that Better Therapeutics Receives FDA Breakthrough Device Designation for Digital Therapeutic Platform Targeting Advanced Liver Disease. Signifies the FDA’s recognition of the Company’s novel
Better Therapeutics Inc [NASDAQ: BTTX] price plunged by -10.16 percent to reach at -$0.02. The one-year BTTX stock forecast points to a potential upside of 88.67. The average equity rating for BTTX stock is currently 1.00, trading closer to a bullish pattern in the stock
© 2024, Powered by Smart TechOne
